BioSpace News Archive

Deals

BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera

Powerful IMO-2125 Data from ILLUMINATE-204 Trial Further Supports Value of Combination

June 5, 2018
·
19 min read
Pharm Country

Risalto Health Raises $1.5M to Improve Patient Outcomes in Musculoskeletal Care

Risalto Health enables patient-centric evidence-based care for patients undergoing back, neck, knee, and hip pain

June 5, 2018
·
3 min read
Biotech Beach

ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio

Patent is directed to a combination of blocking and stimulating the vagus and celiac nerve branches using specific bioelectronic parameters to treat gastrointestinal disorders, including obesity, diabetes, and various combinations thereof.

June 5, 2018
·
5 min read
Business

Williamsburg Landing and K4Connect Announce Partnership to Add Connected-Life Technology

K4Community to be installed across campus, enhancing more than 400 resident homes

June 5, 2018
·
5 min read
BioMidwest

Latest Provider Satisfaction Survey Gives Quantum Health High Marks For Delivering Exceptional Results

Quantum Health, Inc., announces that it has received a Net Promoter Score (NPS) of 75 in its most recent survey of staff working at the front line of healthcare services, including hospital utilization review, case management and physician offices.

June 5, 2018
·
4 min read
BioForest

More than 5,000 Patients Enrolled in Corrona® Psoriasis Registry

The Corrona® Psoriasis Registry announced today that more than 5,000 patients have enrolled in the Corrona Psoriasis Registry.

June 5, 2018
·
3 min read
Biotech Beach

Amplyx Pharmaceuticals to Participate in BIO International Convention Panel and Present at Jefferies Global Healthcare Conference

Amplyx Pharmaceuticals announced that the company’s president and chief executive officer, Ciara Kennedy, Ph.D., will participate in a panel at the 2018 BIO International Convention.

June 5, 2018
·
2 min read
Policy

Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy

Audentes Therapeutics, Inc. announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM).

June 5, 2018
·
4 min read
Pharm Country

Certara Launches Version 8.1 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software; Introduces Professional Certification Program

Certara® announced the launch of Phoenix® 8.1.

June 5, 2018
·
6 min read
Business

Urology Austin Provides Clinical Research as a Care Option to Patients

Urology Austin has partnered with Elligo Health Research.

June 5, 2018
·
2 min read